Literature DB >> 32318919

Pachychoroid disease: a new perspective on exudative maculopathy.

Yasuo Yanagi1,2.   

Abstract

BACKGROUND: Pachychoroid, or the structural and functional abnormalities of the choroid, is one of the most important causes of exudative maculopathies. The purpose of this article is to review the current definitions of pachychoroid and their potential consequences. Most publications are from Asian countries. Although no consensus diagnosis has been reached, pachychoroid is defined by thickened choroid and choroidal vascular hyperpermeability, pachyvessels with inner choroidal attenuation; it is closely linked to pachydrusen. Although some studies suggest choroidal congestion may play a role in its pathogenesis, the exact causes of this condition are still unknown. Pachychoroid is associated with exudative maculopathies including central serous chorioretinopathy, pachychoroid neovasculopathy and polypoidal choroidal vasculopathy (PCV). It is widely accepted that macular neovascular membranes may develop secondary to pachychoroid. Recent clinical observations illustrate the importance of pachychoroid in the etiology of macular neovascularization including neovascular age-related macular degeneration (nAMD).
CONCLUSION: Pachychoroid is an important cause of exudative maculopathies. Both drusen and pachychoroid are increasingly recognized as important causes of macular neovascularization, and eyes formally categorized as typical nAMD or PCV can be further sub-categorized based on the presence or absence of pachychoroid and drusen. There is a need to develop a consensus definition, which will greatly enhance our understanding of pachychoroid and facilitate the development of individual interventions in pachychoroid diseases.

Entities:  

Keywords:  Age-related macular degeneration; Central serous chorioretinopathy; Pachychoroid; Polypoidal choroidal vasculopathy

Mesh:

Year:  2020        PMID: 32318919     DOI: 10.1007/s10384-020-00740-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  23 in total

1.  Cytokine profiles of macular neovascularization in the elderly based on a classification from a pachychoroid/drusen perspective.

Authors:  Satoru Inoda; Hidenori Takahashi; Yuji Inoue; Xue Tan; Hironobu Tampo; Yusuke Arai; Yasuo Yanagi; Hidetoshi Kawashima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-29       Impact factor: 3.117

2.  Association between central serous chorioretinopathy susceptibility genes and choroidal parameters.

Authors:  Kazuya Morino; Masahiro Miyake; Takuro Kamei; Takahisa Kawaguchi; Yuki Mori; Yoshikatsu Hosoda; Akihito Uji; Kenji Yamashiro; Fumihiko Matsuda; Akitaka Tsujikawa
Journal:  Jpn J Ophthalmol       Date:  2022-10-01       Impact factor: 2.211

Review 3.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

4.  Comparison of choroidal hyperreflective spots on optical coherence tomography images between both eyes of normal subjects.

Authors:  Young Ho Kim; Jaeryung Oh
Journal:  Quant Imaging Med Surg       Date:  2022-02

5.  One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.

Authors:  Miki Sato-Akushichi; Shinji Ono; Tatsuro Taneda; Gerd Klose; Asuka Sasamori; Youngseok Song
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-15

6.  Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile.

Authors:  Young Ho Kim; Boram Lee; Edward Kang; Jaeryung Oh
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

7.  Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease.

Authors:  Keiichiro Tanaka; Yasuharu Oguchi; Tomoko Omori; Yumi Ishida; Hiroaki Shintake; Ryutaro Tomita; Akihito Kasai; Masashi Ogasawara; Yukinori Sugano; Kanako Itagaki; Akira Ojima; Takeshi Machida; Hideharu Sekine; Tetsuju Sekiryu
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

8.  Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy.

Authors:  Akiko Miki; Sentaro Kusuhara; Tsuyoshi Otsuji; Yu Kawashima; Katsuaki Miki; Hisanori Imai; Makoto Nakamura; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

Review 9.  Drusen and pachydrusen: the definition, pathogenesis, and clinical significance.

Authors:  Xinyuan Zhang; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2020-11-18       Impact factor: 3.775

10.  Classification of Pachychoroid on Optical Coherence Tomographic En Face Images Using Deep Convolutional Neural Networks.

Authors:  Kook Lee; Ho Ra; Jun Hyuk Lee; Jiwon Baek; Won Ki Lee
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.